Evolocumab Market Emerging Audience, Segments, Market Sales,...

agregó una foto Health

2024-08-03 06:49:31 - Translate -

Evolocumab Market Emerging Audience, Segments, Market Sales, Profits and Regional Study

Evolocumab, a monoclonal antibody, represents a significant advancement in the treatment of hyperlipidemia, particularly in managing elevated low-density lipoprotein cholesterol (LDL-C) levels. Marketed under the brand name Repatha by Amgen, Evolocumab has garnered substantial attention due to its efficacy in reducing LDL-C levels, a critical factor in cardiovascular disease (CVD) management....

0 Commentarios 0 Acciones 2K Views 0 Vista previa